What's New


April 20, 2017 - New York Times: How to Stop Drug Price Gouging

April 11, 2017 - Public Eye: Compulsory Licensing in Colombia: Leaked Documents Show Aggressive Lobbying by Novartis

April 11, 2017 - Press Release: Just Three of World’s Top 28 Pharmaceutical Corporations Agree to Limit Price Hikes to Single Digits

April 11, 2017 - Report: Large Majority of Prescription Drug Corporation CEOs Will Not Commit to Limiting Price Increases

April 10, 2017 - The Intercept: Big Pharma Funds “Independent” Advocacy Groups Attacking Drug-Price Reduction Bill

For older news, visit the Access to Medicines news archive

Improving Access To Affordable Prescription Drugs Act

Public Citizen Materials on the Improving Access To Affordable Prescription Drugs Act

Congressional Press Releases on the Improving Access To Affordable Prescription Drugs Act

Civil Society Endorsers of the Improving Access To Affordable Prescription Drugs Act

  • Alliance for Retired Americans
  • American Family Voices
  • American Federation of State, County and Municipal Employees (AFSCME)
  • American Federation of Teachers (AFT)
  • American Medical Student Association (AMSA)
  • Center for Medicare Advocacy
  • Corporate Accountability International
  • CREDO Action
  • DailyKos
  • Doctors for America
  • Families USA
  • Housing Works
  • Interfaith Center on Corporate Responsibility (ICCR)
  • International Union, United Automobile, Aerospace and Agricultural Implement Workers of America (UAW)
  • MoveOn
  • The Nation
  • National Committee to Preserve Social Security & Medicare
  • National Physicians Alliance
  • NETWORK Lobby for Catholic Social Justice
  • Other98
  • People Demanding Action
  • People for the American Way (PFAW)
  • People of Faith for Access to Medicines (PFAM)
  • Physicians for a National Health Program (PNHP)
  • Public Citizen
  • Sargent Shriver National Center on Poverty Law
  • Social Security Works
  • Universities Allied for Essential Medicines (UAEM)

Press Release: Landmark Legislation Would Lower U.S. Prescription Prices


Public Citizen Applauds Sweeping Bicameral Legislation to Increase Access to Medications for U.S. Consumers and Hold Pharmaceutical Corporations Accountable for Wrongdoing

March 29, 2017

Contact: Don Owens, dowens@citizen.org, (202) 588-7767
Karilyn Gower, kgower@citizen.org, (202) 588-7779

WASHINGTON, D.C. – At a time when the majority of Americans think that lowering the cost of prescriptions should be a top health care priority for the Trump administration and Congress, Public Citizen applauded U.S. Sen. Al Franken’s (D-Minn.) introduction today of the "Improving Access to Affordable Prescription Drugs Act.”

Among other reforms, the legislation would curb the monopoly abuses of pharmaceutical corporations that keep prices high, penalize companies that engage in price gouging, finally allow Medicare to negotiate fair prices for seniors, cap out-of-pocket medicine costs in health insurance plans and require transparency from the pharmaceutical industry. Continue reading...


Back to Access to Medicines Page

Copyright © 2017 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.